Eli Lilly & Co.

Dividend yield
Dividend has grown by 10.49% in last three years.
1.92 %
$2.77 anually
P/E ratio
Payout ratio
Proportion of net income paid out as dividends to shareholders
Company profitability (EPS)
past 12 months
CASH payout ratio
Eli Lilly & Co. last quarter cash income being paid in the form of dividends.
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
See how volatile LLY stock is compared to other dividend stocks and to its sector
past 12 months
Become our supporter to unlock all data!
Company debt level
How much debt Eli Lilly & Co. have in comparison to other dividend stocks
Become our supporter to unlock all data!
Eli Lilly & Co. description

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other.

The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Company profile
Market cap
Mega (147.25B)
Company CEO
David A. Ricks
Price history Eli Lilly & Co.
Loading price stock history...
LLY dividends payouts
Similar stocks as Eli Lilly & Co.